Adverse Effects Impact Treatment Selection for VEGF-Targeted Oral TKIs in Metastatic RCCByCindy Nguyen, PharmD,Dane Fritzsche, PharmD, BCOP,Jina Yun, PharmDDecember 13th 2023Axitinib, cabozantinib, and lenvatinib are first-line treatment options.